Researchers have found that a genetic test can successfully predict whether chemotherapy would be beneficial for patients with the most common type of breast cancer – oestrogen-receptor pos
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
